Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
COVID-19
Pharma
COVID-19 tracker: InflaRx seeks FDA drug authorization
After "encouraging interactions" with the FDA, InflaRx is seeking an emergency use authorization for its lead candidate. Plus more.
Zoey Becker
,
Kevin Dunleavy
,
Fraiser Kansteiner
,
Angus Liu
Sep 30, 2022 10:32am
Moderna urges COVID boosters in latest ad campaign
Sep 30, 2022 10:21am
Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia
Sep 30, 2022 9:15am
Merck, Sinopharm agree on deal for China rights to Lagevrio
Sep 28, 2022 11:36am
Europe's generic drug makers are asking the bloc for a lifeline
Sep 28, 2022 10:49am
The most productive biopharma workforces of 2021
Sep 26, 2022 3:00am
More News
Pfizer and the U.S. have slimmed down a COVID shot donation deal
Sep 23, 2022 10:58am
Pfizer kicks off major Comirnaty COVID vaccine ad campaign
Sep 23, 2022 10:00am
Moderna, Takeda and Everest—Fierce Pharma Asia
Sep 23, 2022 9:25am
Moderna booster supply resumed after FDA cites Catalent plant
Sep 21, 2022 11:23am
See more
